Built on over a decade of clinical development experience, the Research and Development Concierge Company (RDC) was formed in September 2019 by a small group of distinguished clinicians, scientists and business-minded individuals who were determined to change the way clinical research was done for the good of the industry. Change was innovated through an intimate understanding of industry leading companies that took on tough challenges along the way. RDC was not developed overnight, it was molded by experts who care about leading medicine, research, and technology into the future.
Our team members are multifaceted subject matter expertise, technical systems leaders, and result driven collaborators who create a truly personalized, white label, white glove approach to clinical development for today's market. Today we are privileged to connect with sponsors from medical device, biologics, and pharmaceutical portfolios to enhance their R&D portfolios. We are sincerely committed to redefining the clinical development model at its core and accelerating innovation using the concierge method.
The Concierge Method is a personalized approach that adheres to the scientific method. By providing clinical projects a custom-fit solution from start to finish, we have seen a 10-14x savings on Ph 0 - IV studies utilizing our complementary holistic strategies, collectively known as The Concierge Experience (TCx). RDC is committed to advancing tomorrow's best therapies with expertise and precision, at a competitive price..
The R&D Concierge offers these multitude of services through our Study Operator model, taking traditional CRO offerings and turning them on its head. Through one arm, we offer advising and management consulting, hands-on global regulatory leadership, as well as vetted statistical and project management support. Planning and execution is at the center of our strategy. Overall RDC’s unique insight within this space allows us to provide results and keep the overall engagement on track.
Concierge Sites: We proudly provide our clinical site partners with a subscription-based, decentralized research administration service to fulfill site or institutional network research needs. Flat rate & unlimited protocols with a money-back guarantee.
CONCIAR: Save 30% or more on airfare while enjoying extra time with family from time saved on direct travel routes to more destination sites. Our industry-first next-day flight service with Conciar is only possible through our branded CONCIAR experience. We offer a gold-plated membership service that aims to address all the challenges associated with post-pandemic domestic and global travel. We provide this service as the ultimate logistical approach to maximizing a medical researcher’s time and effectiveness.
Concierge Trial Master File (cTMF): Through cutting-edge automation and a no-UI approach, the cTMF was designed to provide maximum efficiency by reducing time allocated to daily tasks to levels well below the industry average. Our cTMF solution was designed to reflect the contours of each study while exceeding all functional needs without additional remapping and beta testing. Our transparent pricing strategy is simple for a fully autonomous solution with a storyboard-map. All that is needed for most engagements is a startup fee and maintenance per our provided best-fit maintenance schedule.
Data Event Synchronize Capture: A Clinical Trial Management and personal-OMICS Ecosystem.
The software platform called DESC (Design Event Synchronize and Capture) combines data analytics and artificial intelligence (AI) which links directly to patient data obtained as part of a clinical trial such as blood pressure monitoring, CT scans, metabolite analyses, genetic tests, and other known medical history and cross-correlates that to the study. The DESC platform is unique in its ability to quickly gather, organize, analyze and validate a patient’s data which is a time-consuming process for pharmaceutical or biomedical companies performing clinical trials. Clinical trials require organizing and monitoring, following protocols, and identifying appropriate patient test populaces. With DESC, clinical trials can occur much faster at a substantially lower cost: this improves our client’s market readiness and operational effectiveness.
RDC also believes great innovation can be achieved when applying AI to the vast amount of patient data, during and after a clinical trial. AI applications can reveal greater insights toward improved long-term care for patients. For instance, patient care could be improved with better diagnostic tools and multivariate tests such as the following:
Gene and biomarker identification for predisposition of disease or body function
Analysis of imaging diagnostics such as radiotherapy for earlier and more accurate detection of disease
Application and use of new therapies, treatments, and products with faster FDA approval and product to market.
The DESC platform will have a natural interface curtailed to your user-role goals, taking in information from all the parameters of a clinical trial. DESC is designed as an AI-first agent which takes in all the different sources of information from patients, doctors, hospitals, and the sponsors running the trials. The DESC dashboard keeps all patient data confidential and in the control of the patients per current privacy laws (HIPAA, HITECH).
Our mission is to allow each patient to have access to their personal health record (PHR) and be able to transfer that data to any hospital or medical clinic efficiently and securely. Our goal is for the patient to always have control of their PHR in a secure manner while having the incredible ability to contribute to research trials and expanding the data pool for an expanding frontier of new research. This is not a new idea, but our digital technology is designed to promote a successful outcome. Using public encryption and a decentralized managed database (our unique blockchain), patient data is kept secure and confidential and inaccessible to cyber-attacks. It is also an abundant reservoir of data which can be applied for specific clinical trials.